Table 2.
Pathways that are differentially regulated between cases with hypertrophic cardiomyopathy and controls with hypertensive left ventricular hypertrophy
| Pathway description | Number of matching proteins | Number of proteins in the pathway | False discovery rate |
|---|---|---|---|
| Cytokine-cytokine receptor interaction | 28 | 263 | 0.0000005 |
| MAPK signaling pathway | 26 | 293 | 0.00003 |
| PI3K-Akt signaling pathway | 28 | 348 | 0.00004 |
| Ras signaling pathway | 21 | 228 | 0.0001 |
| Complement and coagulation cascades | 10 | 78 | 0.004 |
| Apoptosis | 12 | 135 | 0.01 |
| Focal adhesion | 15 | 197 | 0.01 |
| Chemokine signaling pathway | 14 | 181 | 0.01 |
| TNF signaling pathway | 10 | 108 | 0.02 |
| Proteasome | 6 | 43 | 0.03 |
| Rap1 signaling pathway | 14 | 203 | 0.03 |
| ECM-receptor interaction | 8 | 81 | 0.03 |
| ErbB signaling pathway | 8 | 83 | 0.03 |
| TGF-β signaling pathway | 8 | 83 | 0.03 |
| Fluid shear stress and atherosclerosis | 10 | 133 | 0.04 |
| JAK-STAT signaling pathway | 11 | 160 | 0.04 |
ECM = extracellular matrix; JAK = Janus kinase; MAPK = mitogen-activated protein kinase; PI3K = phosphoinositide 3-kinase; STAT = signal transducer and activator of transcription; TGF = transforming growth factor; TNF = tumor necrosis factor